NewGenIvf Group Limited (NIVF)

NASDAQ: NIVF · Real-Time Price · USD

0.9400

-0.0101 (-1.06%)

At close: Mar 28, 2025, 4:00 PM

0.9326

-0.0074 (-0.79%)

Pre-market: Mar 31, 2025, 4:10 AM EDT

NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.68	5.14	5.94	4.12
Revenue Growth (YoY)	-4.46%	-13.59%	44.34%	-
Cost of Revenue	4.19	3.45	4.41	3.09
Gross Profit	1.48	1.68	1.54	1.02
Selling, General & Admin	1.32	1.64	1.14	0.83
Operating Expenses	1.32	1.64	1.14	0.83
Operating Income	0.16	0.04	0.4	0.2
Interest Expense	-0.38	-0.05	-0.08	-0.09
Interest & Investment Income	0	0	0	0
Other Non Operating Income (Expenses)	0.1	0.11	0.02	0.05
Pretax Income	-0.12	0.11	0.34	0.16
Income Tax Expense	-0.08	-	0.21	0.29
Earnings From Continuing Operations	-0.04	0.11	0.14	-0.14
Minority Interest in Earnings	-0.04	0.02	0.32	0.14
Net Income	-0.08	0.13	0.46	-0
Net Income to Common	-0.08	0.13	0.46	-0
Net Income Growth	-	-71.61%	-	-
Shares Outstanding (Basic)	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0
Shares Change (YoY)	1250.11%	6.81%	2.85%	-
EPS (Basic)	-0.21	4.23	15.93	-0.02
EPS (Diluted)	-0.21	4.23	15.93	-0.02
EPS Growth	-	-73.42%	-	-
Free Cash Flow	-2.89	-1.84	1.62	1.42
Free Cash Flow Per Share	-7.44	-59.69	56.13	50.59
Gross Margin	26.14%	32.74%	25.87%	24.88%
Operating Margin	2.84%	0.82%	6.71%	4.83%
Profit Margin	-1.42%	2.54%	7.72%	-0.01%
Free Cash Flow Margin	-50.93%	-35.75%	27.19%	34.39%
EBITDA	0.21	0.07	0.5	0.37
EBITDA Margin	3.63%	1.43%	8.40%	8.88%
D&A For EBITDA	0.04	0.03	0.1	0.17
EBIT	0.16	0.04	0.4	0.2
EBIT Margin	2.84%	0.82%	6.71%	4.83%
Effective Tax Rate	-	-	60.51%	188.70%

Updated Dec 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q